Prakash Radhakrishnan

13PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2025
Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer.

Jayasindu Mathiyazhagan, Christabelle Rajesh, Satish Sagar

|Jul 13, 2024
Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies.

Khadija Turabi, Kelsey Klute, Prakash Radhakrishnan

|Feb 23, 2024
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6.

Eric N Aguilar, Satish Sagar, Brandy R Murray

|May 28, 2022
Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling.

Christabelle Rajesh, Satish Sagar, Ashok Kumar Rathinavel

|Apr 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth.

John Victor Napoleon, Satish Sagar, Sydney P Kubica

|Dec 15, 2021
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.

Sai Kiran Sharma, Kyeara N Mack, Alessandra Piersigilli

Pageof 3